BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29767352)

  • 1. Multifocal motor neuropathy following treatment with adalimumab for ulcerative colitis.
    Fionda L; Vanoli F; Di Pasquale A; Leonardi L; Morino S; Antonini G
    J Neurol; 2018 Jun; 265(6):1466-1468. PubMed ID: 29767352
    [No Abstract]   [Full Text] [Related]  

  • 2. Small-Fiber Neuropathy in a Pediatric Patient Following Anti-Tumor Necrosis Factor-α Therapy for Ulcerative Colitis.
    Breton J; Ellazam B; Haddad E; Deslandres C
    J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):e159-e161. PubMed ID: 29620599
    [No Abstract]   [Full Text] [Related]  

  • 3. Adalimumab-induced apoptotic enteropathy.
    Parikh J; Kerman DH; Garcia-Buitrago MT
    Colorectal Dis; 2016 Apr; 18(4):419-21. PubMed ID: 26799728
    [No Abstract]   [Full Text] [Related]  

  • 4. Adalimumab-Receiving Ulcerative Colitis Patient Suffered Latent Tuberculosis Reactivation Despite Correct Chemoprophylaxis and was Successfully Treated while on Anti-Tumour Necrosis Factor Therapy.
    Agudo B; Díaz G; González-Lama Y
    J Crohns Colitis; 2016 Dec; 10(12):1453-1454. PubMed ID: 27215554
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple cutaneous leishmaniasis in patient with ulcerative colitis under treatment with adalimumab.
    Sánchez-Bernal J; Aldea-Manrique B; Abadías-Granado I; Ara-Martín M
    Med Clin (Barc); 2021 May; 156(9):475. PubMed ID: 32651069
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of concurrent psoriasis and ulcerative colitis with development of arthritis during adalimumab treatment.
    Toyama S; Kanda H; Tateishi S; Yamada A; Sato S; Asano Y
    Eur J Dermatol; 2019 Dec; 29(6):651-653. PubMed ID: 31806587
    [No Abstract]   [Full Text] [Related]  

  • 7. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis.
    Baki E; Zwickel P; Zawierucha A; Ehehalt R; Gotthardt D; Stremmel W; Gauss A
    World J Gastroenterol; 2015 Mar; 21(11):3282-90. PubMed ID: 25805935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab in ulcerative colitis: ready for prime time.
    Danese S
    Dig Liver Dis; 2013 Jan; 45(1):8-13. PubMed ID: 22766323
    [